Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CuminUP60
- Development stage
- Unknown
- Lead developer
- Chenland Nutritionals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
CuminUP60 is a novel formulation of curcumin designed to enhance its bioavailability, which is typically limited by poor water solubility. Developed by Qingdao Chenland Pharmaceutical Technology Development Co., Ltd., the product is manufactured using a solvent-free, co-grinding method. The formulation consists of approximately 65–70% turmeric rhizome extract (standardized to 95% curcumin) and 30–35% of the excipient Kolliphor Poloxamer 407. It has been evaluated in clinical trials at The Affiliated Hospital of Qingdao University to compare its pharmacokinetic profile against standard curcumin capsules in healthy adult subjects. Curcumin is known for its diverse biological activities, including anti-inflammatory and antioxidant properties, which CuminUP60 aims to leverage more effectively through improved absorption.
- Brand names
- CuminUP60CuminUP-60CuminUP 60
- Other names
- CuminUP60 capsulesCuminUP-60 capsulesCuminUP 60 capsules
02
Targets
AMPK/mTOR axis (AMPK / mTOR signaling axis)
Beyond the preview
Go deeper on CuminUP60.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CuminUP60.